TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pensa Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/03 | 2023/03 | 2021/12 |
| Turnover |
1,316
|
2,836
|
3,837 |
| Financial expenses |
2
|
9
|
0 |
| Earnings before taxes |
-147
|
-329
|
105 |
| EBITDA |
120
|
-295
|
98 |
| Total assets |
1,473
|
2,537
|
2,847 |
| Current assets |
1,471
|
1,996
|
1,733 |
| Current liabilities |
284
|
911
|
684 |
| Equity capital |
1,190
|
1,626
|
2,164 |
| - share capital |
87
|
89
|
98 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/03 | 2023/03 | 2021/12 |
| Solvency |
80.8%
|
64.1%
|
76.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-11.2%
|
-11.6%
|
2.7% |
| Return on assets (ROA) |
-9.8%
|
-12.6%
|
3.7% |
| Current ratio |
518.0%
|
219.1%
|
253.4% |
| Return on equity (ROE) |
-12.4%
|
-20.2%
|
4.9% |
| Change turnover |
-1,459
|
-644
|
1,643 |
| Change turnover % |
-53%
|
-19%
|
75% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/03 | 2023/03 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.